Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

We came across a bullish thesis on Zoetis Inc. (ZTS) on Best Anchor Stocks’ Substack. In this article, we will summarize the ...

The companion animal vaccines products market is expected to reach USD 3,964.7 million by 2025 and is expected to steadily grow at a CAGR of 4.2% to reach USD 5,982.7 million by 2035. In 2024, ...

The Middle East veterinary vaccine market is expected to reach approximately USD 678.3 million in 2025 and expand to around USD 1,053.3 million by 2035, reflecting a compound annual growth rate (CAGR) ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...

The veterinary vaccines market is estimated to reach USD 9,433.9 million in 2024. It is estimated that revenue will increase ...

We recently published a list of Jim Cramer Talked About These 10 Stocks Recently. In this article, we are going to take a ...

The Chautauqua County Health Department is partnering with the Pet Pantry and Lakeshore Humane Society to offer free rabies ...

Dog owners across the country are grieving after their pets died following use of a widely prescribed pain medicine, raising ...

Zoetis sells anti-infectives, vaccines, parasiticides ... and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward ...

Valued at a market cap of $70.9 billion, Zoetis Inc. (ZTS) discovers, develops, manufactures, and commercializes animal health medicines, vaccines, diagnostic products and services, biodevices, ...